ContraFect
CFRX
$0.05000
Share price
-27.95%
Change (1 day)
-97.77%
Change (1 year)
Categories
EPS for ContraFect (CFRX)
EPS in 2023 (TTM): -$53.17
According to ContraFect's latest financial reports the company's current EPS (TTM) is -$53.17. In 2022 the company made an earnings per share (EPS) of -$128.33 a decrease over its 2021 EPS that were of -$44.80.
EPS history for ContraFect from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$53.17 | -58.57% |
| 2022 | -$128.33 | 186.45% |
| 2021 | -$44.80 | -62.16% |
| 2020 | -$118.40 | 4.96% |
| 2019 | -$112.80 | -72.88% |
| 2018 | -$416.00 | 73.33% |
| 2017 | -$240.00 | -65.12% |
| 2016 | -$688.00 | -19.63% |
| 2015 | -$856.00 | -54.85% |
| 2014 | -$1,896 | 7.37% |
| 2013 | -$1,766 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Viking Therapeutics
VKTX | -$0.93 | -98.25% | 🇺🇸 USA |
 Prometheus Biosciences RXDX | -$3.52 | -93.38% | 🇺🇸 USA |